http://www.lipocine.com
Lipocine Inc. Company Intro
IMPROVED DRUG ABSORPTION | BETTER PATIENT COMPLIANCE Improving Health We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine … Home Read More »
Industry
Healthcare
Lipocine Inc. Headquaters
675 Arapeen Drive
Salt Lake City,84108
United States
Lipocine Inc. Share price
22 Oct 2020 02:01 GMT
$1.3500
-0.01 (-0.74 %)
Lipocine Inc. Market cap
$87.361 M
WMC RANKING
2020
Lipocine Inc. # 261
BiotechnologyLatest Lipocine Inc. News
21 Oct 2020
Long-Term Bull Case Remains Untouched: ATIF Holdings Limited (ATIF) and Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN) shares on Tuesday's trading session, dropped -0.73 percent to see the stock exchange hands at $1.36 per unit. Lets a quick look at ...
21 Oct 2020
Long-Term Bull Case Remains Untouched: ATIF Holdings Limited (ATIF) and Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN) shares on Tuesday's trading session, dropped -0.73 percent to see the stock exchange hands at $1.36 per unit. Lets a quick look at ...
21 Oct 2020
Long-Term Bull Case Remains Untouched: ATIF Holdings Limited (ATIF) and Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN) shares on Tuesday's trading session, dropped -0.73 percent to see the stock exchange hands at $1.36 per unit. Lets a quick look at ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Lipocine Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 19 | 0 | 0 | 98.79 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.02 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 100 | 0 | 0 | 90.93 |
Lipocine Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Lipocine Inc. | $165 | $5,597 | $-13,007 | $87.361M | 261 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |